Navidea Biopharmaceuticals Inc (NAVB)

[palantir]

NEWS>>>>>1."Lymphoseek® Performance vs. Sulfur Colloid in Breast Cancer Patients Published in Annals of Surgical Oncology; Fewer Nodal Dissections Required" http://www.marketwatch.com/story/lymphoseek-performance-vs-sulfur-colloid-in-breast-cancer-patients-published-in-annals-of-surgical-oncology-fewer-nodal-dissections-required-2015-01-29?siteid=nbsh

2.CD206 patent application
http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=/netahtml/PTO/search-adv.html&r=1&p=1&f=G&l=50&d=PG01&S1=navidea&OS=navidea&RS=navidea

COMPOSITIONS, METHODS AND KITS FOR DIAGNOSING AND TREATING CD206 EXPRESSING CELL-RELATED DISORDERS

Abstract
A method of diagnosing a CD206 expressing cell-related disorder by administering a pharmaceutical composition to a subject, the composition including a carrier molecule having a detectable moiety attached thereto. The carrier molecule has a dextran backbone, and at least one receptor substrate conjugated, directly or indirectly, to the dextran backbone, wherein the receptor substrate is chosen so as to specifically bind to CD206. A method of treating a CD206 expressing cell-related disorder is also provided, as well as an ex vivo method and kit for quantitating the number of cells expressing CD206 in a bodily fluid.

note: whiners need not read....